|
1
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bataller R and Brenner DA: Hepatic
stellate cells as a target for the treatment of liver fibrosis.
Semin Liver Dis. 21:437–451. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reeves HL and Friedman SL: Activation of
hepatic stellate cells-a key issue in liver fibrosis. Front Biosci.
7:d808–d826. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Inagaki Y and Okazaki I: Emerging insights
into transforming growth factor beta Smad signal in hepatic
fibrogenesis. Gut. 56:284–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ouchi N, Oshima Y, Ohashi K, Higuchi A,
Ikegami C, Izumiya Y and Walsh K: Follistatin-like 1, a secreted
muscle protein, promotes endothelial cell function and
revascularization in ischemic tissue through a nitric-oxide
synthase-dependent mechanism. J Biol Chem. 283:32802–32811. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kudo-Saito C: FSTL1 promotes bone
metastasis by causing immune dysfunction. Oncoimmunology.
2:e265282013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Adams D, Larman B and Oxburgh L:
Developmental expression of mouse Follistatin-like 1 (Fstl1):
Dynamic regulation during organogenesis of the kidney and lung.
Gene Expr Patterns. 7:491–500. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kudo-Saito C, Fuwa T, Murakami K and
Kawakami Y: Targeting FSTL1 prevents tumor bone metastasis and
consequent immune dysfunction. Cancer Res. 73:6185–6193. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC
and Cheung AN: Tumor suppressor effect of follistatin-like 1 in
ovarian and endometrial carcinogenesis: A differential expression
and functional analysis. Carcinogenesis. 30:114–121. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong Y, Geng Y, Li L, Li X, Yan X, Fang Y,
Li X, Dong S, Liu X, Li X, et al: Blocking follistatin-like 1
attenuates bleomycin-induced pulmonary fibrosis in mice. J Exp Med.
212:235–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang W, Yang M, Song L, Shen K, Wang H,
Gao X, Li M, Niu W and Qin X: Isolation and culture of hepatic
stellate cells from mouse liver. Acta Biochim Biophys Sin
(Shanghai). 46:291–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maruyama S, Nakamura K, Papanicolaou KN,
Sano S, Shimizu I, Asaumi Y, van den Hoff MJ, Ouchi N, Recchia FA
and Walsh K: Follistatin-like 1 promotes cardiac fibroblast
activation and protects the heart from rupture. EMBO Mol Med.
8:949–966. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murphy N, Gaynor KU, Rowan SC, Walsh SM,
Fabre A, Boylan J, Keane MP and McLoughlin P: Altered expression of
bone morphogenetic protein accessory proteins in murine and human
pulmonary fibrosis. Am J Pathol. 186:600–615. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Svegliati-Baroni G, Ridolfi F, Hannivoort
R, Saccomanno S, Homan M, De Minicis S, Jansen PL, Candelaresi C,
Benedetti A and Moshage H: Bile acids induce hepatic stellate cell
proliferation via activation of the epidermal growth factor
receptor. Gastroenterology. 128:1042–1055. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khan F, Peltekian KM and Peterson TC:
Effect of interferon-alpha, ribavirin, pentoxifylline, and
interleukin-18 antibody on hepatitis C sera-stimulated hepatic
stellate cell proliferation. J Interferon Cytokine Res. 28:643–651.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bendia E, Benedetti A, Baroni GS,
Candelaresi C, Macarri G, Trozzi L and Di Sario A: Effect of
cyanidin 3-O-beta-glucopyranoside on hepatic stellate cell
proliferation and collagen synthesis induced by oxidative stress.
Dig Liver Dis. 37:342–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Si HF, Lü X, Guo A and Jiang H:
Suppressive effects of leflunomide on leptin-induced TIMP-1
production involves on hepatic stellate cell proliferation and
apoptosis. Eur J Pharmacol. 580:63–69. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He Y, Huang C, Sun X, Long XR, Lv XW and
Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate
cell proliferation by targeting SMAD4. Cell Signal. 24:1923–1930.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wiercinska E, Wickert L, Denecke B, Said
HM, Hamzavi J, Gressner AM, Thorikay M, ten Dijke P, Mertens PR,
Breitkopf K and Dooley S: Id1 is a critical mediator in
TGF-beta-induced transdifferentiation of rat hepatic stellate
cells. Hepatology. 43:1032–1041. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He P, Yu ZJ, Sun CY, Jiao SJ and Jiang HQ:
Knockdown of eIF3a attenuates the pro-fibrogenic response of
hepatic stellate cells induced by TGF-β1. Cell Mol Biol
(Noisy-le-grand). 62:107–111. 2016.PubMed/NCBI
|
|
23
|
Ma HH, Yao JL, Li G, Yao CL, Chen XJ and
Yang SJ: Effects of c-myb antisense RNA on TGF-beta1 and beta1-I
collagen expression in cultured hepatic stellate cells. World J
Gastroenterol. 10:3662–3665. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo JY, Zhang LT, Ming-Xia LU, Yan XM,
Xiao P and Medicine DO: Smurf 2 impact on TGF-β/Smad pathway in
liver fibrosis. Med Recapitulate. 17:125–131. 2015.
|
|
25
|
Zhou Y, Tong X, Ren S, Wang X, Chen J, Mu
Y, Sun M, Chen G, Zhang H and Liu P: Synergistic anti-liver
fibrosis actions of total astragalus saponins and glycyrrhizic acid
via TGF-β1/Smads signaling pathway modulation. J Ethnopharmacol.
190:83–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang JW and Wook K: The role of Pin1 in
liver fibrosis: Regulation of Tgf-β1 expression and Smad2/3
phosphorylation. Toxicol Lett. 229 Suppl:S2402014. View Article : Google Scholar
|
|
27
|
Breitkopf K, Weng H and Dooley S:
TGF-β/Smad-signaling in liver cells: Target genes and inhibitors of
two parallel pathways. Signal Transduction. 6:329–337. 2006.
View Article : Google Scholar
|
|
28
|
Zhang L, Liu C, Meng XM, Huang C, Xu F and
Li J: Smad2 protects against TGF-β1/Smad3-mediated collagen
synthesis in human hepatic stellate cells during hepatic fibrosis.
Mol Cell Biochem. 400:17–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
